JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32576

Anti-MEK1 antibody [Y77]

  • 20ul selling size
  • KO Validated
  • RabMAb
  • Recombinant
  • What is this?

Be the first to review this product! Submit a review

|

(24 Publications)

Knockout Tested Rabbit Recombinant Monoclonal MEK1 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 24 publications.

View Alternative Names

MEK1, PRKMK1, MAP2K1, Dual specificity mitogen-activated protein kinase kinase 1, MAP kinase kinase 1, MAPKK 1, MKK1, ERK activator kinase 1, MAPK/ERK kinase 1, MEK 1

12 Images
Immunocytochemistry/ Immunofluorescence - Anti-MEK1 antibody [Y77] (AB32576)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-MEK1 antibody [Y77] (AB32576)

Immunocytochemistry/ Immunofluorescence analysis of A431 (Human epidermoid carcinoma epithelial cell) cells labeling MEK1 with purified ab32576 at 1/50 dilution (6.6 μg/ml). Cells were fixed in 100% Methanol. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1 : 200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MEK1 antibody [Y77] (AB32576)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MEK1 antibody [Y77] (AB32576)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human kidney tissue sections labeling MEK1 with purified ab32576 at 1/100 dilution (3.28 μg/ml). Heat mediated antigen retrieval was performed using heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MEK1 antibody [Y77] (AB32576)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MEK1 antibody [Y77] (AB32576)

ab32576 (unpurified) at a 1/250 dilution staining MEK1 in human urinary bladder carcinoma tissue by IHC-P.

Immunocytochemistry/ Immunofluorescence - Anti-MEK1 antibody [Y77] (AB32576)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-MEK1 antibody [Y77] (AB32576)

Immunocytochemistry/Immunofluorescence analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) labeling MEK1 with purified ab32576 at 1/500 dilution (5 μg/ml). Cells were fixed with 4% PFA and permeabilized with 0.1% triton X-100. ab150077 Goat anti rabbit IgG (Alexa Fluor® 488) at 1/1000 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI. PBS was used instead of the primary antibody as the negative control.

Flow Cytometry (Intracellular) - Anti-MEK1 antibody [Y77] (AB32576)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-MEK1 antibody [Y77] (AB32576)

Intracellular Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling MEK1 with purified ab32576 at 1/30 dilution (10μg/ml) (red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluorr® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Immunoprecipitation - Anti-MEK1 antibody [Y77] (AB32576)
  • IP

Unknown

Immunoprecipitation - Anti-MEK1 antibody [Y77] (AB32576)

ab32576 (purified) at 1/20 dilution (2ug) immunoprecipitating MEK1 in Jurkat whole cell lysate. Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate 10ug
Lane 2 (+) : ab32576 & Jurkat whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab32576 in Jurkat whole cell lysate
For western blotting, VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-MEK1 antibody [Y77] (ab32576)

Predicted band size: 43 kDa

false

Western blot - Anti-MEK1 antibody [Y77] (AB32576)
  • WB

Lab

Western blot - Anti-MEK1 antibody [Y77] (AB32576)

Western blot : Anti-MAP2K1 antibody [Y77] (ab32576) staining at 1/10000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab32576 was shown to bind specifically to MAP2K1. A band was observed at 45 kDa in wild-type A549 cell lysates with no signal observed at this size in MAP2K1 knockout cell line. To generate this image, wild-type and MAP2K1 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-MEK1 antibody [Y77] (ab32576) at 1/10000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

MAP2K1 knockout A549 cell lysate at 20 µg

Lane 3:

Wild-type HAP1 cell lysate at 20 µg

Lane 4:

MAP2K1 knockout HAP1 cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Predicted band size: 43 kDa

Observed band size: 45 kDa

false

Western blot - Anti-MEK1 antibody [Y77] (AB32576)
  • WB

Unknown

Western blot - Anti-MEK1 antibody [Y77] (AB32576)

All lanes:

Western blot - Anti-MEK1 antibody [Y77] (ab32576) at 1/10000 dilution

All lanes:

Jurkat (Human T cell leukemia cell line from peripheral blood) cell lysate

Predicted band size: 43 kDa

Observed band size: 45 kDa

false

Western blot - Anti-MEK1 antibody [Y77] (AB32576)
  • WB

Lab

Western blot - Anti-MEK1 antibody [Y77] (AB32576)

Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : MEK1 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : A431 whole cell lysate (20 μg)
Lane 4 : HepG2 whole cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab32576 (unpurified) observed at 43 kDa. Red - loading control, ab18058, observed at 130 kDa.

ab32576 was shown to specifically react with MEK1 in wild-type HAP1 cells as signal was lost in MEK1 knockout cells. Wild-type and MEK1 knockout samples were subjected to SDS-PAGE. ab32576 and ab18058 (Mouse anti-Vinculin loading control) were incubated overnight at 4°C at 1/10000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-MEK1 antibody [Y77] (ab32576)

Predicted band size: 43 kDa

false

Western blot - Anti-MEK1 antibody [Y77] (AB32576)
  • WB

Supplier Data

Western blot - Anti-MEK1 antibody [Y77] (AB32576)

Blocking and diluting buffer and concentration : 1% BSA/TBST. The identity of the higher MW bands between 100kDa and 200kDa are unknown. Lysates were freshly made and used for Western blotting immediately to minimize protein degradation. In Western blot, anti-GAPDH antibody (ab181602) loading control staining at 1/200000 dilution. In Western blot, anti-MEK1 antibody (ab32576) loading control staining at 1/1000 dilution. Exposure time : 26 seconds.

All lanes:

Western blot - Anti-MEK1 (phospho T286) antibody [EPR27226-8] (<a href='/en-us/products/primary-antibodies/mek1-phospho-t286-antibody-epr27226-8-ab307509'>ab307509</a>) at 1/1000 dilution

Lane 1:

Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg

Lane 2:

HeLa treated with 100ng/ml nocodazole for 24h whole cell lysate (untreated membrane) at 20 µg

Lane 3:

HeLa treated with 100ng/ml nocodazole for 24h whole cell lysate (phosphatase treated membrane at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 43 kDa

Observed band size: 43 kDa

false

Exposure time: 26s

Western blot - Anti-MEK1 antibody [Y77] (AB32576)
  • WB

Supplier Data

Western blot - Anti-MEK1 antibody [Y77] (AB32576)

Blocking and diluting buffer and concentration : 1% BSA/TBST. The identity of the higher MW bands between 100kDa and 200kDa are unknown. Lysates were freshly made and used for Western blotting immediately to minimize protein degradation. In Western blot, anti-GAPDH antibody (ab181602) loading control staining at 1/200000 dilution. In Western blot, anti-MEK1 antibody (ab32576) loading control staining at 1/1000 dilution. Exposure time : 15 seconds.

All lanes:

Western blot - Anti-MEK1 (phospho T286) antibody [EPR27226-8] (<a href='/en-us/products/primary-antibodies/mek1-phospho-t286-antibody-epr27226-8-ab307509'>ab307509</a>) at 1/1000 dilution

Lane 1:

Untreated wild-type HAP1(human chronic myelogenous leukemia near-haploid cell line) whole cell lysate (untreated membrane), at 20 µg

Lane 2:

Wild-type HAP1 treated with 100ng/ml nocodazole for 24h whole cell lysate (untreated membrane) at 20 µg

Lane 3:

untreated MEK1 knockout HAP1 whole cell lysate at 20 µg

Lane 4:

MEK1 knockout HAP1 treated with 100ng/ml nocodazole for 24h whole cell lysate at 20 µg

Lane 5:

Untreated wild-type HAP1 whole cell lysate (phosphatase treated membrane), at 20 µg

Lane 6:

Wild-type HAP1 treated with 100ng/ml nocodazole for 24h whole cell lysate (phosphatase treated membrane) at 20 µg

Lane 7:

Untreated MEK1 knockout HAP1 whole cell lysate (phosphatase treated membrane) at 20 µg

Lane 8:

MEK1 knockout HAP1 treated with 100ng/ml nocodazole for 24h whole cell lysate (phosphatase treated membrane) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 43 kDa

Observed band size: 43 kDa

false

Exposure time: 15s

Western blot - Anti-MEK1 antibody [Y77] (AB32576)
  • WB

Lab

Western blot - Anti-MEK1 antibody [Y77] (AB32576)

All lanes:

Western blot - Anti-MEK1 antibody [Y77] (ab32576) at 1/10000 dilution

Lane 1:

Jurkat (Human T cell leukemia T lymphocyte) whole cell lysates at 20 µg

Lane 2:

HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 43 kDa

Observed band size: 45 kDa

false

  • 578 PE

    PE Anti-MEK1 antibody [Y77]

  • Carrier free

    Anti-MEK1 antibody [Y77] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

Y77

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB, IP, ICC/IF, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The antibody does not crossreact with other MAP kinase kinase family members.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/20 - 1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/30 - 1/40", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MEK1 also known as MAP2K1 is a dual-specificity kinase that plays a role in the MAPK/ERK pathway. It has a molecular weight of around 45 kDa. MEK1 phosphorylates and activates the extracellular signal-regulated kinases ERK1 and ERK2. MEK1 is expressed in various tissues but is especially abundant in brain and heart tissues. Researchers commonly measure MEK1 levels using techniques like MEK1 ELISA while phospho-MEK antibodies help analyze its activity state.
Biological function summary

MEK1 impacts cell processes such as proliferation differentiation and survival. It does not work alone but forms a complex with other proteins to exert its function. MEK1 activity is tightly controlled by upstream activators and downstream targets. One of the key phosphorylation sites on MEK1 is at serine 298 often marked as MEK1 pS298. This phosphorylation indicates MEK1's activated state which is critical for its biological function.

Pathways

MEK1 integrates signals within the MAPK/ERK pathway and interacts closely with RAF kinases upstream and ERK kinases downstream. This pathway modulates cellular responses to growth factors. MEK1 undergoes phosphorylation enhancing its activity and subsequently phosphorylates ERK proteins. Many studies isolate MEK1 activity using specific inhibitors such as the MEK1 inhibitor to dissect pathway dynamics. ERK inhibitor PD98059 also helps when studying parallel interactions with MEK1.

MEK1 mutations or dysregulation have links to several types of cancer including melanoma. These often involve changes that lead to continuous MEK1 activation contributing to uncontrolled cell growth. MEK1 involvement in the RASopathies also shows its connection to disorders characterized by heart and facial abnormalities. In cancer MEK1 works closely with the BRAF protein which often harbors mutations leading to disease progression showcasing MEK1 as a target for therapeutic intervention.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed : 29433126). Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.
See full target information MAP2K1

Publications (24)

Recent publications for all applications. Explore the full list and refine your search

Open medicine (Warsaw, Poland) 20:20251206 PubMed40918165

2025

Peptide CCAT1-70aa promotes hepatocellular carcinoma proliferation and invasion via the MAPK/ERK pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xianjian Wu,Ruifeng Liang,Guoman Liu,Quan Fang,Zuoming Xu,Wenchuan Li,Chuan Tan,Jian Pu

Molecular pain 21:17448069251346373 PubMed40407181

2025

TLR3 mediates central sensitization in a chronic migraine model induced by repeated nitroglycerin through the ERK signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Bin Yang,Zhaoming Ge

Journal of clinical medicine 12: PubMed37373600

2023

Exosomes Derived from Colon Cancer Cells Promote Tumor Progression and Affect the Tumor Microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Minsung Kim,Il Tae Son,Gyoung Tae Noh,So-Youn Woo,Ryung-Ah Lee,Bo Young Oh

International journal of oncology 61: PubMed36263632

2022

PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Huijun Cao,Zhiqiang Wang,Ying Wang,Lijuan Ye,Ruilei Li,Yuanbo Xue,Ke Li,Tiannan Di,Tao Li,Zonglin Fan,Yanyan Liu,Jiyin Guo,Hong Yao,Chunlei Ge

Balkan medical journal 39:267-274 PubMed35872627

2022

FLOT2 Promotes the Proliferation and Epithelial-mesenchymal Transition of Cervical Cancer by Activating the MEK/ERK1/2 Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Li,Shulan Dou

Aging 14:5390-5405 PubMed35771155

2022

MIR503HG impeded ovarian cancer progression by interacting with SPI1 and preventing TMEFF1 transcription.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Tian,Lei Yang,Zhongtai Wang,Haiya Yan

Cell death discovery 8:164 PubMed35383161

2022

Gastric cancer cell-derived extracellular vesicles elevate E2F7 expression and activate the MAPK/ERK signaling to promote peritoneal metastasis through the delivery of SNHG12.

Applications

Unspecified application

Species

Unspecified reactive species

Fangbin Zhang,Changqing Guo,Xinguang Cao,Yan Yan,Jinping Zhang,Shuai Lv

ACS chemical biology 17:322-330 PubMed35119255

2022

High-Throughput Cellular Thermal Shift Assay Using Acoustic Transfer of Protein Lysates.

Applications

Unspecified application

Species

Unspecified reactive species

Ashley E Owens,Michael J Iannotti,Tino W Sanchez,Ty Voss,Abhijeet Kapoor,Matthew D Hall,Juan J Marugan,Sam Michael,Noel Southall,Mark J Henderson

Cancers 13: PubMed34885115

2021

The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Wen-Chien Huang,Vijesh Kumar Yadav,Wei-Hong Cheng,Chun-Hua Wang,Ming-Shou Hsieh,Ting-Yi Huang,Shiou-Fu Lin,Chi-Tai Yeh,Kuang-Tai Kuo

Frontiers in cell and developmental biology 9:708562 PubMed34900980

2021

HUWE1 Causes an Immune Imbalance in Immune Thrombocytopenic Purpura by Reducing the Number and Function of Treg Cells Through the Ubiquitination Degradation of Ets-1.

Applications

Unspecified application

Species

Unspecified reactive species

Jianqin Li,Yalin Xia,Xiaoru Fan,Xiaofang Wu,Feiyun Yang,Shaoyan Hu,Zhaoyue Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com